Pressure BioSciences Completes Second Tranche of Offering

Jun 22, 2011

NEW YORK (GenomeWeb News) – Pressure BioSciences said after the close of the market Tuesday that it has completed the second tranche of its private placement raising gross proceeds of $275,475.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

PLOS Papers Look at Gut Mycobacterium Abscessus, Preterm Birth Transcriptomics, More

In PLOS this week: Mycobacterium abscessus linked to gastric conditions, placental gene expression changes associated with preterm birth, and more.

All That Plastic in the Lab

The Guardian reports that UK universities are looking into ways to reduce labs' reliance on single-use plastics.

Garlic Helps, Too

People with certain gene variants tend to not like vegetables, particularly bitter ones, CNN reports.

Now Here

MIT's Technology Review reports on a company's genetic test that gauges an embryo's susceptibility to certain diseases.

Featured White Papers

KAPA RNA HyperPrep: A Streamlined Library Preparation Workflow that Enables Robust Gene Expression Profiling Using RNA-sequencing

Orthogonal Methods for Validation and Confirmation of Next-Generation Sequencing Results

Efficient High-Throughput SNP Discovery and Genotyping using Normalized Genotyping-by-Sequencing

SeqSNP Targeted GBS as Alternative for Array Genotyping in Routine Breeding Programs

Nov

13

Featured Webinar

Targeted Detection of MET and NTRK Oncogenic Variants in Routine Molecular Analysis

This webinar will discuss advances in detecting MET and NTRK variants in tumor samples, which can help clinicians determine the appropriate therapy for cancer patients.

Dec

02

Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Dec

04

Featured Webinar

Integrating Genetic Data in Clinical Workflows: How CCPM Established a Personalized Health Framework

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).

Menu

Pressure BioSciences Completes Second Tranche of Offering

To read the full story....

Breaking News

Castle Biosciences Q3 2019 Revenues Quadruple

Researchers Develop CRISPR Method for Dose-Dependent Gene Expression Activation

Top Five Articles on GenomeWeb Last Week: Thermo Fisher, Alzheimer's Disease, Merck, and More

MDxHealth Revenues Down 35 Percent for Nine-Month 2019 Period

Chatbots Could Help Human Genetic Counselors Focus on Patient Concerns

Expedeon to Sell Proteomics, Immunology Businesses to Abcam for $130M

The Scan

PLOS Papers Look at Gut Mycobacterium Abscessus, Preterm Birth Transcriptomics, More

All That Plastic in the Lab

Garlic Helps, Too

Now Here

Featured White Papers

Targeted Detection of MET and NTRK Oncogenic Variants in Routine Molecular Analysis

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Integrating Genetic Data in Clinical Workflows: How CCPM Established a Personalized Health Framework

What's Popular?

10x Genomics' Fully Automated Single-Cell Library Prep Platform Coming in Early 2020

ChromaCode Debuts Instrument-Agnostic Multiplex Panel for Multi-Drug Resistant Infection Screening

Bioneer Gets CE Mark for HCV Assay

Merck, Promega Collaborate to Develop MSI CDx for Keytruda

OraSure Strives for End-to-End Presence in Microbiome Market with Diversigen Buy

Sponsorships